Rigel

Pipeline


Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders.


View Product Pipeline

News

Events
© 2015 Rigel  |  privacy  |  disclaimer | Follow Us On:     contact us  |  site map  |  search    Search
built@zoomedia.com